Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 17.99% is 34% below its 5-year average of 27.36%, near the low end of its 5-year range (17.39%–70.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.76% below its 12-month average of 25.61%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): 17.99%.
RETURN ON INVESTED CAPITAL (ROIC)
17.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
25.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
22.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
27.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.76%
CURRENT VS 3Y AVG
-19.46%
CURRENT VS 5Y AVG
-34.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.27%
median of 645 covered companies
CURRENT VS SECTOR MEDIAN
+154.07%
vs the sector median at left
Embecta Corp.
Market Cap
$355.67M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
25.61%
3Y Avg
22.34%
5Y Avg
27.36%
Market Cap
$356.36M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-2.07%
3Y Avg
-43.39%
5Y Avg
-53.01%
Market Cap
$356.50M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$354.49M
Return on Invested Capital (ROIC)
-56.73%
TTM Avg
-80.02%
3Y Avg
-65.94%
5Y Avg
-165.76%
Market Cap
$359.46M
Return on Invested Capital (ROIC)
-93.74%
TTM Avg
-188.84%
3Y Avg
-156.74%
5Y Avg
-129.07%
Market Cap
$348.59M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$365.97M
Return on Invested Capital (ROIC)
-59.29%
TTM Avg
-166.84%
3Y Avg
-79.03%
5Y Avg
-92.27%
Market Cap
$342.30M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$374.07M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-10.82%
3Y Avg
-40.29%
5Y Avg
-33.17%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Embecta Corp. (EMBC) | $355.67M | 17.99% | 25.61% | 22.34% | 27.36% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.36M | -1.84% | -2.07% | -43.39% | -53.01% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $356.50M | -24.20% | -33.45% | -34.14% | -28.75% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $354.49M | -56.73% | -80.02% | -65.94% | -165.76% |
| Ocugen, Inc. (OCGN)vs › | $359.46M | -93.74% | -188.84% | -156.74% | -129.07% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | -27.16% | -54.52% | -49.44% | -51.83% |
| Opus Genetics, Inc. (IRD)vs › | $365.97M | -59.29% | -166.84% | -79.03% | -92.27% |
| Agenus Inc. (AGEN)vs › | $342.30M | N/A | -35.18% | -129.73% | -103.61% |
| Canopy Growth Corporation (CGC)vs › | $374.07M | -10.85% | -10.82% | -40.29% | -33.17% |
| Cabaletta Bio, Inc. (CABA)vs › | $333.45M | -85.56% | -114.55% | -77.72% | -63.50% |
ROIC
18.0%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 17.99% |
| 2026-03-31 | 25.88% |
| 2025-12-31 | 29.39% |
| 2025-09-30 | 27.19% |
| 2025-06-30 | 27.60% |
| 2025-03-31 | 26.96% |
| 2024-12-31 | 23.88% |
| 2024-09-30 | 19.12% |
| 2024-06-30 | 19.20% |
| 2024-03-31 | 18.85% |
| 2023-12-31 | 17.85% |
| 2023-09-30 | 17.39% |
| 2023-06-30 | 19.05% |
| 2023-03-31 | 26.33% |
| 2022-12-31 | 33.94% |
| 2022-09-30 | 41.17% |
| 2022-06-30 | 43.64% |
| 2022-03-31 | 57.04% |
| 2021-12-31 | 70.04% |
| 2021-09-30 | 66.10% |
